Submit Deal

ANTENGENE

Summary

Antengene operates as a specialty pharmaceutical company. The Company produces innovative drugs, selinexor, eltanexor, verdinexor, and other products. Antengene provides its services throughout China.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 72 M

Avg. Deal Size£ 72 M

Market Context

Senior Management

Jay Mei
CEO

Sort

linklaters

HQ - London

legal advisors (1)

1 Shared Deal

1 Opposite

£ 72 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy